Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy

Bexarotene is a third-generation retinoid X receptor-selective retinoid that is widely used for the early treatment of advanced-stage cutaneous T-cell lymphomas. In this report, we describe a case of successful treatment of advanced primary cutaneous peripheral T-cell lymphoma not otherwise specifie...

Full description

Bibliographic Details
Main Authors: Yota Sato, Taku Fujimura, Yumi Kambayashi, Akira Hashimoto, Setsuya Aiba
Format: Article
Language:English
Published: Karger Publishers 2018-03-01
Series:Case Reports in Oncology
Subjects:
Primary cutaneous peripheral T-cell lymphoma not otherwise specified
Cutaneous T-cell lymphomas
Treatment
Bexarotene monotherapy
Online Access:https://www.karger.com/Article/FullText/488236

Internet

https://www.karger.com/Article/FullText/488236

Similar Items